Geneva Advisors’s Illumina ILMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-2,544
Closed -$401K 737
2016
Q1
$401K Buy
+2,544
New +$389K 0.01% 477
2015
Q3
Sell
-6,633
Closed -$1.41M 668
2015
Q2
$1.41M Buy
6,633
+3,549
+115% +$693K 0.03% 259
2015
Q1
$557K Sell
3,084
-2,209
-42% -$416K 0.01% 393
2014
Q4
$950K Buy
+5,293
New +$933K 0.02% 308
2014
Q3
Sell
-8,897
Closed -$1.54M 721
2014
Q2
$1.54M Buy
+8,897
New +$1.33M 0.03% 243

Other funds holding ILMN

Geneva Advisors's ILMN Position: Q2 2016 in Review

Geneva Advisors sold out of Illumina (ILMN) in Q2 2016, closing a stake of 2,544 shares — an estimated $401K sold.

Geneva Advisors first reported a position in ILMN in Q2 2014 and held it in 5 quarters. The position peaked at $1.54M in Q2 2014. 525 funds tracked by Wall St. Rank hold ILMN as of Q2 2016.

  • Geneva Advisors reported no remaining Illumina position as of Q2 2016 after selling out during the quarter.
  • Geneva Advisors sold 2,544 Illumina shares in Q2 2016, an estimated $401K.
  • Geneva Advisors first reported a position in Illumina in Q2 2014 and held it in 5 quarters.
  • Geneva Advisors's Illumina position peaked at $1.54M in Q2 2014.
  • 525 funds tracked by Wall St. Rank held Illumina as of Q2 2016.

Based on Geneva Advisors's 13F filing for Q2 2016, filed 8 Aug 2016.